A new report entitled ‘Extracting Opportunities’ has been published by SW4 Partners, in collaboration with CIC member Lawrence Stephens and Artemis Growth Partners. The report focuses on the evolving extract-based cannabis medicines market in Europe, and combines detailed analysis with engaging content to highlight the opportunities and complexities of this sector. Download the report here. […]
Read More
The CIC is pleased to announce that Paul North has become our new Advocacy Representative. Paul will also sit on the CIC’s Executive Committee. Paul is the Director of CIC member Volteface, a leading organisation in the cannabis industry – which both provides commercial services, and manages one of the most visited cannabis news sites […]
Read More
The new European Pharmacopoeia monograph on Cannabis flower (3028) has reportedly been officially published in Ph. Eur. Supplement 11.5, according to GMP-Compliance. The monograph had been pre-published in October 2023 on the European Directorate for the Quality of Medicines & HealthCare (EDQM), Council of Europe website. GMP-Compliance notes a number of additional requirements have been […]
Read More
A commitment to supporting the UK’s military community and veterans – known as the Armed Forces Covenant – has been signed by the Cannabis Industry Council (CIC). The signed pledge states: “We commit to uphold the Armed Forces Covenant and support the Armed Forces Community. We recognise the contribution that Service personnel, both regular and […]
Read More
Highly experienced and innovative business leader Stef Kulik has joined the Board of the Cannabis Industry Council (CIC) as a Non Executive Director. Stef is currently managing director of the health division of a well-known British brand. He has previously worked in the consumer goods industry, in private equity, venture capital, and for a number […]
Read More
Expanding the prescription cannabis market will lead to improved outcomes for ethnic minorities, women, and the LGBT community, according to a new report from the Cannabis Industry Council (CIC). The report, entitled ‘ESG Benefits of an Expanded Medicinal Cannabis Market’, highlights how the current situation results in many potential patients either not seeking a prescription […]
Read More
The total number of prescription cannabis patients has now reached 32,000, according to CIC Honorary President Prof. Mike Barnes. Prof. Barnes gave the latest estimate during his speech at this year’s Patient Conference, held on 3 November in London. Commenting later on X (Twitter), Prof. Barnes clarified the process for obtaining the figures: “This number […]
Read More
A patient survey has been launched by the Cannabis Industry Council, to coincide with Medical Cannabis Awareness Week (1-7 November). Both current and former prescription cannabis patients can complete the survey here. The survey results will better enable the Cannabis Industry Council to understand the challenges patients face, and to advocate for improved outcomes with […]
Read More
Drugs Minister Chris Philp MP has stated that the amount of medical cannabis imported into the UK in 2023 has more than tripled, when compared to last year. Responding to a Parliamentary question, Mr Philp said that up to 19 September this year, the UK had imported 23,890 KG of cannabis (in base drug form). […]
Read More
A draft Bill to enable general medical practitioners (GPs) to initiate cannabis medicine prescriptions has been published by the Cannabis Industry Council (CIC). The CIC and its lawyers believe that the most straightforward process would be to make three simple amendments to section 4 of The Misuse of Drugs (Amendments) (Cannabis and Licence Fees) (England, Wales […]
Read More